ArticleCritical care (London, England)2008

Filter survival time and requirement of blood products in patients with severe sepsis receiving drotrecogin alfa (activated) and requiring renal replacement therapy.

Luigi Camporota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.